Display options
Cite
Chen I, Raymond VM, Geis JA, et al. Ultrasensitive plasma ctDNA . Oncotarget. 2017;8(58):97769-97786doi: 10.18632/oncotarget.22080.
Chen, I., Raymond, V. M., Geis, J. A., Collisson, E. A., Jensen, B. V., Hermann, K. L., Erlander, M. G., Tempero, M., & Johansen, J. S. (2017). Ultrasensitive plasma ctDNA . Oncotarget, 8(58), 97769-97786. https://doi.org/10.18632/oncotarget.22080
Chen, Inna, et al. "Ultrasensitive plasma ctDNA ." Oncotarget vol. 8,58 (2017): 97769-97786. doi: https://doi.org/10.18632/oncotarget.22080
Chen I, Raymond VM, Geis JA, Collisson EA, Jensen BV, Hermann KL, Erlander MG, Tempero M, Johansen JS. Ultrasensitive plasma ctDNA . Oncotarget. 2017 Oct 26;8(58):97769-97786. doi: 10.18632/oncotarget.22080. eCollection 2017 Nov 17. PMID: 29228650; PMCID: PMC5716690.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2017 Oct 26;8(58):97769-97786. doi: 10.18632/oncotarget.22080. eCollection 2017 Nov 17.

Ultrasensitive plasma ctDNA .

Oncotarget

Inna Chen, Victoria M Raymond, Jennifer A Geis, Eric A Collisson, Benny V Jensen, Kirstine L Hermann, Mark G Erlander, Margaret Tempero, Julia S Johansen

Affiliations

  1. Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  2. Trovagene, Inc., San Diego, California, USA.
  3. Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  4. Department of Radiology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  5. Department of Medicine, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  6. Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

PMID: 29228650 PMCID: PMC5716690 DOI: 10.18632/oncotarget.22080

Abstract

Precision oncology requires sensitive and specific clinical biomarkers. Carbohydrate Antigen 19-9 (CA19-9) is widely used in pancreatic ductal adenocarcinoma (PDA) but lacks sensitivity and specificity. Nearly all PDAs harbor somatic

Keywords: CA19-9; KRAS; ctDNA; pancreatic ductal adenocarcinoma; prognostic biomarker

Conflict of interest statement

CONFLICTS OF INTEREST VMR, JAG and MGE are full time employees of Trovagene, Inc.

References

  1. Gastroenterology. 1987 Jan;92(1):60-7 - PubMed
  2. Oncotarget. 2016 Nov 8;8(48):83446-83456 - PubMed
  3. Cancer Res. 2012 May 15;72(10):2457-67 - PubMed
  4. C R Seances Soc Biol Fil. 1948 Feb;142(3-4):241-3 - PubMed
  5. Clin Cancer Res. 1998 Feb;4(2):271-5 - PubMed
  6. Clin Cancer Res. 1998 Jun;4(6):1527-32 - PubMed
  7. Clin Cancer Res. 2017 Jul 15;23 (14 ):3657-3666 - PubMed
  8. Sci Transl Med. 2014 Feb 19;6(224):224ra24 - PubMed
  9. Gastroenterology. 2015 Oct;149(5):1131-3 - PubMed
  10. Gastrointest Cancer Res. 2011 Jan;4(1):15-21 - PubMed
  11. J Gastrointest Oncol. 2012 Jun;3(2):105-19 - PubMed
  12. J Thorac Oncol. 2016 Oct;11(10 ):1690-700 - PubMed
  13. Ann Intern Med. 1989 May 1;110(9):704-9 - PubMed
  14. J Clin Oncol. 1999 Feb;17(2):578-84 - PubMed
  15. N Engl J Med. 2011 May 12;364(19):1817-25 - PubMed
  16. Clin Cancer Res. 2017 Jan 1;23 (1):116-123 - PubMed
  17. Clin Chem. 2016 Nov;62(11):1482-1491 - PubMed
  18. Am J Pathol. 1993 Aug;143(2):545-54 - PubMed
  19. Cancer Res. 1987 Oct 15;47(20):5501-3 - PubMed
  20. N Engl J Med. 2013 Oct 31;369(18):1691-703 - PubMed
  21. J Clin Oncol. 2014 Feb 20;32(6):579-86 - PubMed
  22. Clin Lung Cancer. 2014 May;15(3):182-7 - PubMed
  23. Cancer. 1988 May 15;61(10):2100-8 - PubMed
  24. Breast Cancer Res. 2015 Nov 17;17 :140 - PubMed
  25. Arch Surg. 2006 Oct;141(10):968-73; discussion 974 - PubMed
  26. Nat Clin Pract Urol. 2005 Aug;2(8):416-22 - PubMed
  27. Clin Chem Lab Med. 2013 Jul;51(7):1369-83 - PubMed
  28. Mol Oncol. 2016 Apr;10 (4):635-43 - PubMed
  29. Lancet. 2016 Jul 2;388(10039):73-85 - PubMed
  30. Pancreas. 2008 Oct;37(3):269-74 - PubMed
  31. Adv Exp Med Biol. 2016;924:13-17 - PubMed
  32. Lancet Oncol. 2008 Feb;9(2):132-8 - PubMed
  33. Br J Cancer. 2003 Oct 20;89(8):1413-7 - PubMed
  34. Eur J Cancer. 2009 Jan;45(2):228-47 - PubMed
  35. Br J Cancer. 2000 Mar;82(5):1013-6 - PubMed
  36. Br J Cancer. 2005 Jan 31;92(2):405-12 - PubMed
  37. Nat Commun. 2015 Apr 09;6:6744 - PubMed
  38. JAMA Oncol. 2016 Sep 1;2(9):1209-16 - PubMed
  39. Nature. 2015 Feb 26;518(7540):495-501 - PubMed
  40. Cancer. 1983 Jun 1;51(11):2116-20 - PubMed
  41. Asia Pac J Clin Oncol. 2010 Jun;6(2):98-105 - PubMed
  42. Transl Lung Cancer Res. 2015 Feb;4(1):36-54 - PubMed
  43. Eur J Surg Oncol. 2010 Jul;36(7):657-62 - PubMed
  44. Cancer. 2015 Jul 1;121(13):2271-80 - PubMed
  45. Cancer. 2013 Jan 15;119(2):285-92 - PubMed
  46. Front Oncol. 2013 Jun 14;3:155 - PubMed
  47. Cancer Res. 1977 Mar;37(3):646-50 - PubMed
  48. Pancreas. 2002 Nov;25(4):336-41 - PubMed
  49. Cancer Discov. 2014 Jun;4(6):650-61 - PubMed
  50. Br J Cancer. 2005 Jul 25;93(2):195-9 - PubMed
  51. J Gastroenterol. 2004 Jan;39(1):56-60 - PubMed
  52. Cell. 1988 May 20;53(4):549-54 - PubMed
  53. Br J Cancer. 2002 Aug 27;87(5):551-4 - PubMed
  54. JAMA. 2014 Jan 22-29;311(4):392-404 - PubMed
  55. Nat Med. 2015 Jul;21(7):795-801 - PubMed

Publication Types